Calcification is one of the main causes for bioprosthetic heart valves (BHVs)’ failure. Reported strategies to improve BHVs’ anti-calcification properties only target some of risk factors for calcification. In the… Click to show full abstract
Calcification is one of the main causes for bioprosthetic heart valves (BHVs)’ failure. Reported strategies to improve BHVs’ anti-calcification properties only target some of risk factors for calcification. In the current study, we demonstrated dopamine-modified alginate coating served as a protected layer for BHVs’ anti-calcification. Alginate coating was characterized by infrared spectroscopic analysis, ultraviolet spectrophotometer, and water contact angle test. By both high-calcium and high-phosphorus in vitro calcification model and rat subdermal implant in vivo calcification model, our results showed alginate-coated BHVs’ have greatly improved BHVs’ anti-calcification performance due to constant ionic exchange of calcium and sodium. Besides, alginate-coated BHVs did not change BHVs’ mechanical strength and tissue’s shrink temperature. This was the first proof-of-concept study to verify that alginate coating would be a novel method for BHVs’ anti-calcification.
               
Click one of the above tabs to view related content.